Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 June 2007

Heart. Published Online First: 25 October 2006. doi:10.1136/hrt.2006.097477
Copyright © 2006 BMJ Publishing Group Ltd & British Cardiovascular Society

Original articles

Trimetazidine in the Prevention of Contrast-Induced Nephropathy After Coronary Procedures

Alper O Onbasili 1*, Yavuz Yenicerioglu 2, Pynar Agaoglu 1, Aslihan Karul 3, Tarkan Tekten 1, Harun Akar 2 and Guzel Discigil 4

1 Department of Cardiology, Adnan Menderes University, Turkey
2 Department of Nephrology, Adnan Menderes University, Turkey
3 Department of Biochemistry, Adnan Menderes University, Turkey
4 Department of Familiy Medicine, Adnan Menderes University, Turkey

* To whom correspondence should be addressed. E-mail: onbasili{at}isbank.net.tr.

Accepted 19 September 2006


Abstract

Background This study was designed to evaluate the efficacy of trimetazidine (TMZ) in the prevention of contrast induced nephropathy (CIN) in patients with high serum creatinine levels undergoing coronary angiography/angioplasty.

Methods Eighty-two (25 Female, 57 Male, mean age 60iÀ10 years) consecutive patients with a serum creatinin level iY1,2 mg/dl undergoing coronary procedures were randomly assigned into two groups: TMZ (n=40) and control (n=42). Trimetazidine (20 mg t.i.d.) was administered orally. All patients were given intravenous saline (0,9%) at a rate of 1 ml/kg of body weight per hour. Serum creatinine concentrations were measured before, 48 hours and 7 days after the procedure. Increase in serum creatinine level exceeding 0,5 mg/d or 1/4 of basal is considered as CIN. Venous blood samples for serum total antioxidant capacity (TAC) measurement were drawn before and after coronary angiography.

Results Basal serum creatinine levels and TAC were similar in TMZ and control groups. However, serum creatinine levels 2 days after the procedure in the control group increased significantly and it returned to the baseline values at 7th day. However, it did not change significantly at 2nd day and even significantly decreased at 7th day in TMZ group. CIN developed 2,5% (1/40) of patients in the TMZ group and in 16,6% (7/42) of patients in the control group (p<0.05). TAC values were not different between treatment groups.

Conclusion TMZ along with isotonic saline infusion is more effective than isotonic saline alone in reducing the risk of CIN in patients with preexisting renal dysfunction.

Keywords: Contrast-induced nephropathy, Coronary intervention, Trimetazidine


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

WEB TOP 10
Heart 2007 93: 1023. [Extract] [Full Text] [PDF]

Preventing contrast nephropathy in catheter laboratory
Jeffrey W H Fung, Check C Szeto, and Cheuk M Yu
Heart 2007 93: 654-655. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Fung, J. W H, Szeto, C. C, Yu, C. M (2007). Preventing contrast nephropathy in catheter laboratory. Heart 93: 654-655 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.